Haemophagocytic lymphohistiocytosis complicating visceral leishmaniasis in the UK: a case for detailed travel history, a high index of suspicion and timely diagnostics.
Amphotericin B
/ therapeutic use
Antiprotozoal Agents
/ therapeutic use
Dexamethasone
/ therapeutic use
Fever
/ etiology
Glucocorticoids
/ therapeutic use
Humans
Infant
Leishmaniasis, Visceral
/ complications
Lymphohistiocytosis, Hemophagocytic
/ complications
Male
Polymerase Chain Reaction
Spain
Travel
United Kingdom
global health
haematology (incl blood transfusion)
immunology
infectious diseases
tropical medicine (infectious disease)
Journal
BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291
Informations de publication
Date de publication:
10 Jul 2019
10 Jul 2019
Historique:
entrez:
13
7
2019
pubmed:
13
7
2019
medline:
9
1
2020
Statut:
epublish
Résumé
A 4-month-old male infant presented acutely unwell with fever. He was initially treated for sepsis but failed to improve with IV broad spectrum antibiotics. Haemophagocytic lymphohistiocytosis (HLH) was diagnosed due to his fever, pancytopenia, splenomegaly, hypertriglyceridaemia, hypofibrinogenaemia and significant hyperferritinaemia. An array of differentials for HLH including both immunological and infectious causes were considered and excluded. He had travelled to Madrid, and hence visceral leishmaniasis (VL) was suspected, but was not confirmed on the initial bone marrow aspirate (BMA) microscopy or culture. He improved with empirical treatment with dexamethasone and liposomal amphotericin B. VL was later confirmed on BMA PCR. He made a good recovery and remained well at 12 month follow-up. Non-endemic countries need rapid and sensitive VL diagnostics. A thorough travel history and high clinical index of suspicion are necessary to avoid the pitfall of treatment with intense immunosuppression recommended in treatment guidelines for HLH.
Identifiants
pubmed: 31296633
pii: 12/7/e228307
doi: 10.1136/bcr-2018-228307
pmc: PMC6626435
pii:
doi:
Substances chimiques
Antiprotozoal Agents
0
Glucocorticoids
0
liposomal amphotericin B
0
Dexamethasone
7S5I7G3JQL
Amphotericin B
7XU7A7DROE
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):351-4
pubmed: 27408434
Blood. 2002 Oct 1;100(7):2367-73
pubmed: 12239144
J Infect. 2008 May;56(5):381-8
pubmed: 18405976
Pediatr Infect Dis J. 2015 Jun;34(6):667-9
pubmed: 25970110
Arch Dis Child. 2011 Jul;96(7):688-93
pubmed: 20584844
J Pediatr. 2014 Jul;165(1):147-153.e1
pubmed: 24797953
Pediatrics. 2000 Oct;106(4):E58
pubmed: 11015553
J Infect Dev Ctries. 2016 Jan 31;10(1):103-8
pubmed: 26829545
J Blood Med. 2014 Jun 12;5:69-86
pubmed: 24966707
Blood. 2012 Mar 22;119(12):2754-63
pubmed: 22294731